KR102526197B9 - Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1 - Google Patents

Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1

Info

Publication number: KR102526197B9
Authority: KR; South Korea
Prior art keywords: cotl1; composition; bone diseases; treating bone; diagnosis
Prior art date: 2019-11-19

Application number

KR1020200155080A

Other languages

Korean (ko)

Other versions

KR102526197B1 (en

KR20210061289A (en

Inventor

정선용

박은국

Original Assignee

아주대학교산학협력단

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-11-19

Filing date

2020-11-19

Publication date

2023-11-13

2020-11-19 Application filed by 아주대학교산학협력단 filed Critical 아주대학교산학협력단

2020-11-19 Priority to US17/777,460 priority Critical patent/US20220403030A1/en

2020-11-19 Priority to PCT/KR2020/016333 priority patent/WO2021101259A1/en

2021-05-27 Publication of KR20210061289A publication Critical patent/KR20210061289A/en

2023-04-27 Application granted granted Critical

2023-04-27 Publication of KR102526197B1 publication Critical patent/KR102526197B1/en

2023-11-13 Publication of KR102526197B9 publication Critical patent/KR102526197B9/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Marine Sciences & Fisheries (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

KR1020200155080A 2019-11-19 2020-11-19 Composition for diagnosis, preventing or treating bone diseases comprising cotl1 KR102526197B1 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
US17/777,460 US20220403030A1 (en)	2019-11-19	2020-11-19	Composition, comprising cotl1 as active ingredient, for diagnosis of bone disease or obesity
PCT/KR2020/016333 WO2021101259A1 (en)	2019-11-19	2020-11-19	Composition, comprising cotl1 as active ingredient, for diagnosis of bone disease or obesity

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR20190149077		2019-11-19
KR1020190149077		2019-11-19

Publications (3)

Publication Number	Publication Date
KR20210061289A KR20210061289A (en)	2021-05-27
KR102526197B1 KR102526197B1 (en)	2023-04-27
KR102526197B9 true KR102526197B9 (en)	2023-11-13

Family

ID=76135856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
KR1020200155080A KR102526197B1 (en)	2019-11-19	2020-11-19	Composition for diagnosis, preventing or treating bone diseases comprising cotl1

Country Status (1)

Country	Link
KR (1)	KR102526197B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20220153830A (en)	2021-05-12	2022-11-21	주식회사 엘지에너지솔루션	Test connector for inspecting a connector with pins pushed back

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3012634B1 (en)	2013-06-21	2019-01-02	Catholic University Industry-Academic Cooperation Foundation	Biomarker for rheumatoid arthritis diagnosis or activity evaluation
KR20160048442A (en)	2014-10-24	2016-05-04	가톨릭대학교 산학협력단	Biomarkers related to rheumatoid arthritis
CN110066866B (en) *	2019-01-17	2021-12-07	浙江大学	Biomarkers of osteoarthritis fourth subtype and uses

2020
- 2020-11-19 KR KR1020200155080A patent/KR102526197B1/en active IP Right Grant

Also Published As

Publication number	Publication date
KR102526197B1 (en)	2023-04-27
KR20210061289A (en)	2021-05-27

Similar Documents

Publication	Publication Date	Title
IL275754A (en)	2020-08-31	Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
EP3954395A4 (en)	2023-06-28	Pharmaceutical composition for muscle disease treatment
ZA202006610B (en)	2022-08-31	Compositions for the treatment of skin conditions
IL287796A (en)	2022-01-01	Compositions and methods for the treatment of atpase-mediated diseases
IL288958A (en)	2022-02-01	Exosomes for disease treatment
SG11202107325TA (en)	2021-08-30	Methods and compositions for the treatment of fabry disease
EP4000609A4 (en)	2023-07-26	Pharmaceutical composition for preventing or treating bone diseases
SG11202012070YA (en)	2021-01-28	Methods and compositions for preventing or treating tissue calcification
IL289213A (en)	2022-02-01	Pharmaceutical composition for treating tumor
IL257229A (en)	2018-03-29	Blood applicator for tissue treatment
IL291351A (en)	2022-05-01	Compositions for the treatment of solid tumors
EP3827837A4 (en)	2022-05-04	Composition for preventing or treating immune-related diseases
SG11202007082PA (en)	2020-08-28	Composition used for therapeutic treatment of skin disease
IL288793A (en)	2022-02-01	Compounds for treating respiratory disease
KR102526197B9 (en)	2023-11-13	Cotl1 composition for diagnosis preventing or treating bone diseases comprising cotl1
PT3574912T (en)	2021-03-26	Composition for treating diabetic disease
EP3927375A4 (en)	2022-11-23	Compositions for disease treatment
EP3936124A4 (en)	2023-02-15	Pharmaceutical composition for preventing or treating neurological diseases
PL3810128T3 (en)	2023-01-30	Compositions for treating and/or preventing protein-aggregation diseases
EP3925623A4 (en)	2022-11-09	Medicinal composition for preventing or treating bone diseases
KR102090101B9 (en)	2021-07-14	Oral composition for preventation or treatment of oral disease
ZA202107235B (en)	2023-10-25	Compositions and methods for treating ocular disease
KR102276379B9 (en)	2022-03-15	IF1 ATPase inhibitory factor 1 Composition for Preventing or Treating Bone Diseases Comprising IF1
IL280589A (en)	2021-03-25	Compositions for the treatment of graft versus host disease
EP4052694A4 (en)	2023-09-20	Eye drop composition for preventing or treating eye disease

Legal Events

Date	Code	Title
2022-08-21	E902	Notification of reason for refusal
2023-02-23	E701	Decision to grant or registration of patent right
2023-11-13	G170	Re-publication after modification of scope of protection [patent]